Early adoption of non-pharmaceutical interventions and COVID-19 mortality

被引:15
|
作者
Amuedo-Dorantes, Catalina [1 ]
Borra, Cristina [2 ]
Rivera-Garrido, Noelia [3 ]
Sevilla, Almudena [4 ]
机构
[1] Univ Calif Merced, Econ, 5200 North Lake Rd, Merced, CA 95343 USA
[2] Univ Seville, Econ & Econ Hist, Ramon y Cajal 1, Seville 41018, Spain
[3] Univ Loyola Andalucia, Econ, Avda Univ S-N, Seville 41704, Spain
[4] UCL, Social Sci, Gower St, London WC1E 6BT, England
关键词
COVID-19; Coronavirus; Lockdown; Mortality; Pandemic; Spain;
D O I
10.1016/j.ehb.2021.101003
中图分类号
F [经济];
学科分类号
02 ;
摘要
To contain the spread of the COVID-19 pandemic, many countries around the globe have adopted social distancing measures. Yet, establishing the causal effect of non-pharmaceutical interventions (NPIs) is difficult because they do not occur arbitrarily. We exploit a quasi-random source of variation for identification purposes -namely, regional differences in the placement on the pandemic curve following an unexpected and nationwide lockdown. Our results reveal that regions where the outbreak had just started when the lockdown was implemented had 1.62 fewer daily deaths per 100,000 inhabitants when compared to regions for which the lockdown arrived 10+ days after the pandemic's outbreak. As a result, a total of 4,642 total deaths (232 deaths/daily) could have been avoided by the end of our period of study -a figure representing 23% of registered deaths in Spain at the time. We rule out differential pre-COVID mortality trends and self-distancing behaviors across the compared regions prior to the swift lockdown, which was also uniformly observed nationwide. In addition, we provide supporting evidence for contagion deceleration as the main mechanism behind the effectiveness of the early adoption of NPIs in lowering the death rate, rather than an increased healthcare capacity. (C) 2021 Elsevier B.V. All rights reserved.
引用
收藏
页数:15
相关论文
共 50 条
  • [21] Applying the health belief model to examine college students' early stage adoption of non-pharmaceutical interventions in response to COVID-19
    Hatteberg, Sarah J.
    Kollath-Cattano, Christy
    JOURNAL OF AMERICAN COLLEGE HEALTH, 2024, 72 (02) : 340 - 345
  • [22] Commentary: Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe
    Kuhbandner, Christof
    Homburg, Stefan
    FRONTIERS IN MEDICINE, 2020, 7
  • [23] COVID-19 modeling and non-pharmaceutical interventions in an outpatient dialysis unit
    Jang, Hankyu
    Polgreen, Philip M.
    Segre, Alberto M.
    Pemmaraju, Sriram V.
    PLOS COMPUTATIONAL BIOLOGY, 2021, 17 (07)
  • [24] Effect of Non-pharmaceutical Interventions on COVID-19 in Rwanda: An Observational Study
    Rwagasore, Edson
    Nsekuye, Olivier
    Rutagengwa, Alfred
    El-Khatib, Ziad
    JOURNAL OF EPIDEMIOLOGY AND GLOBAL HEALTH, 2023, 13 (02) : 239 - 247
  • [25] Mathematical modeling of COVID-19: Impact of non-pharmaceutical interventions in India
    Bajiya, Vijay Pal
    Bugalia, Sarita
    Tripathi, Jai Prakash
    CHAOS, 2020, 30 (11)
  • [26] Analysis of non-pharmaceutical interventions impacts on COVID-19 pandemic in Iran
    Saadatmand, Sara
    Salimifard, Khodakaram
    Mohammadi, Reza
    NONLINEAR DYNAMICS, 2022, 109 (01) : 225 - 238
  • [27] Reflective model assessment of adherence to COVID-19 non-pharmaceutical interventions
    Pavic, M. P.
    Pranic, S. M.
    Matelic, T.
    Kljucevic, Z.
    Gotovac, M.
    Savicevic, A. Jurcev
    Kozina, T.
    Kozina, S.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2024, 34
  • [28] Impact of non-pharmaceutical interventions on the COVID-19 epidemic: A modelling study
    Awaidy, Salah Al
    Mahomed, Ozayr
    SAGE OPEN MEDICINE, 2020, 8
  • [29] Analysis of non-pharmaceutical interventions impacts on COVID-19 pandemic in Iran
    Sara Saadatmand
    Khodakaram Salimifard
    Reza Mohammadi
    Nonlinear Dynamics, 2022, 109 : 225 - 238
  • [30] Vaccination and non-pharmaceutical interventions for COVID-19: a mathematical modelling study
    Moore, Sam
    Hill, Edward M.
    Tildesley, Michael J.
    Dyson, Louise
    Keeling, Matt J.
    LANCET INFECTIOUS DISEASES, 2021, 21 (06): : 793 - 802